PremiumCompany AnnouncementsAstraZeneca Buys Global Rights to Dizal’s Zegfrovy in $1.5bn Lung Cancer Deal15h agoAZN
PremiumCompany AnnouncementsAstraZeneca Advances AZD5004 Combo Data With Diabetes Drugs, Offering Subtle Upside for AZN Investors1d agoAZN
AstraZeneca Advances AZD5004 Combo Data With Diabetes Drugs, Offering Subtle Upside for AZN Investors